登录 | 注册    关注公众号  
微信公众号
搜索
 > 【FGF basic】

FGF basic信息

英文名称:Fibroblast growth factor 2
中文名称:成纤维细胞生长因子2
靶点别称:FGF-2,Heparin-binding growth factor 2,Basic fibroblast growth factor,FGFB,bFGF,HBGF-2,FGF2,Fibroblast Growth Factor 2 (Basic),Basic Fibroblast Growth Factor BFGF,Prostatropin,Fibroblast Growth Factor 2
上市药物数量:1
临床药物数量:3
最高研发阶段:批准上市

FGF basic产品列表

ACRO质量管理体系
 
评论(2)
FGC-H81E3|Biotinylated Human FGF basic Protein, Avitag™,His Tag (MALS verified)
  1. 152XXXXXXX7
  2. 0人赞
  3. 用于ELISA实验,抗原产品性能出众,与预期抗体结合力强,灵敏度高,特异性好。很快就得到满意的试验结果,为后续项目进展提供了很大帮助。
  4. 2024-04-11
BFF-H4117|Human FGF basic Protein, premium grade
  1. 152XXXXXXX7
  2. 0人赞
  3. FGF2抗原稳定性好,用于亲和力检测以及,HUVEC的增殖抑制实验都效果很好。包装精美,发货快,批号统一,推荐ACRO的抗原。
  4. 2024-04-11
 

FGF basic分子别名

FGF2,BFGF,FGFB,FGF basic,HBGF-2

FGF basic分子背景

FGF basic is a member of the FGF family of at least 23 related mitogenic proteins which show 35-60% amino acid conservation. FGF acidic and basic, unlike the other members of the family, lack signal peptides and are apparently secreted by mechanisms other than the classical protein secretion pathway. FGF basic has been isolated from a number of sources, including neural tissue, pituitary, adrenal cortex, corpus luteum, and placenta. This factor contains four cysteine residues, but reduced FGF basic retains full biological activity, indicating that disulfide bonds are not required for this activity. bFGF is a critical component of human embryonic stem cell culture medium; the growth factor is necessary for the cells to remain in an undifferentiated state, although the mechanisms by which it does this are poorly defined. It has been demonstrated to induce gremlin expression which in turn is known to inhibit the induction of differentiation by bone morphogenetic proteins. It is necessary in mouse-feeder cell dependent culture systems, as well as in feeder and serum-free culture systems.

FGF basic上市药物信息

英文名称 中文名称 研发代码 研发阶段 公司 最早商品名 最早批准国家 最早适应症 最早批准公司 最早批准日期 适应症 临床试验
Thalidomide 沙利度胺 NSC-66847; NSC-527179; K-17; VP-02; FPF-300; FPF300 批准上市 新基公司 Talizer, Thalidomide Celgene, Thalidomide Pharmion, Synovir, Thalomid, Thaled Mainland China 麻风结节性红斑, 多发性骨髓瘤 Changzhou Pharmaceutical Factory 1982-01-01 HIV消耗综合征, 血管发育不良, 骨髓纤维化, 原始神经外胚层肿瘤, 前列腺炎, 结直肠癌, 骨肉瘤, 套细胞淋巴瘤, 尤因肉瘤, 视网膜母细胞瘤, 结节性红斑, 耐药性癫痫, 口腔干燥, 肉瘤, 慢性胰腺炎, 透明细胞腺癌, 滤泡性淋巴瘤, 蛛网膜炎, 腺鳞癌, 胃肠道出血, 原发性硬化性胆管炎, 前列腺癌, 盆腔疼痛, 转移癌, 口腔炎, 口灼伤综合征, 胞内分枝杆菌感染, 肌萎缩性侧索硬化, 黑色素瘤, 骨髓增生异常-骨髓增生性疾病, 肝细胞癌, 慢性淋巴细胞白血病, 血管畸形, 结核分枝杆菌感染, 阑尾肿瘤, 非霍奇金淋巴瘤, 子宫肿瘤, 铁粒幼细胞性贫血, 胶质瘤, 麻风结节性红斑, 子宫内膜癌, 肺癌, 华氏巨球蛋白血症, 肾肿瘤, 地中海贫血, 类癌瘤, 盘状红斑狼疮, 口腔炎,口疮, 横纹肌肉瘤, 咳嗽, 卵巢癌, 动静脉畸形, 分支杆菌感染, 头颈癌, 难治性贫血伴原始细胞过多, 平滑肌肉瘤, 白血病, 肝癌 详情

FGF basic临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
Muparfostat sodium PI-88 临床三期 澳洲国立大学 实体瘤, 肝癌, 肿瘤, 小细胞肺癌, 前列腺癌, 肺癌, 肝细胞癌, 非小细胞肺癌, 黑色素瘤 详情
RBM-007 ID3 (21); APT-F2; RBM-007 临床二期 Ribomic 软骨发育不全, 年龄相关性黄斑变性 详情
Fibroblast growth factor 2 gene therapy (ID Pharma) SeV-10101; SEV-10101; DVC-10101; BF-30 临床二期 Dnavec 动脉闭塞性疾病, 间歇性跛行, 缺血, 外周动脉疾病, 周围动脉闭塞性疾病 详情

消息提示

请输入您的联系方式,再点击提交!

确定